The global flow diverters market size is anticipated to reach USD 722.59 million by 2030, to expand at a CAGR of 13.22% according to a new report by Grand View Research, Inc. Rising awareness about minimally invasive treatment option, regulatory approvals, collaboration and partnerships, along with growing research activity in the field of brain aneurysm treatment are driving the market growth.
Increasing number of patients suffering from hypertension significantly increases the risk of brain aneurysm. For instance, as per the Barcelona Institute for Global Health (ISGlobal) in 2022, Hypertension is one of the top causes of death worldwide, accounting for 12.8% of all fatalities each year. Furthermore, as per the WHO in 2023, worldwide, an estimated 1.28 billion persons aged 30-79 years have hypertension, with the majority (two-thirds) living in middle and low income nations. These factors are expected to increase the demand in the coming years.
Several initiatives launched by the government of various countries to improve public awareness and treatment related to cerebral aneurysm are anticipated to spur the demand in near future. For instance, the Brain Aneurysm Foundation of Canada works toward spreading awareness and educating about brain aneurysm. This programs include and social media campaigns early access to monthly educational webinars for highlighting the prevalence of brain aneurysm.
Companies are developing and launching technologically advanced products for attracting more customers in the market. For instance, in January 2020, MicroVention, Inc. (a subsidiary of Terumo Corporation) has gained FDA Premarket Clearance for their FRED, which is used to treat cerebral aneurysms. It makes use of a self-expanding, woven nitinol mesh to reroute blood flow and facilitate aneurysm closure which is expected to boost the demand in the near future.
Request a free sample copy or view report summary: Flow Diverters Market Report
Based on diameter size, >5 mm flow diverter segment dominated the overall market with a share of 65.41% in 2022 owing to their increasing demand and application in treating giant and wide intracranial aneurysms (>10 mm vessel diameter).
North America dominated the market with the highest revenue with a share of 36.06% in 2022 owing to high prevalence rate of brain aneurysm and presence of key market players in this region.
Asia Pacific is expected to grow at highest compound annual growth rate (CAGR) of 14.00% from 2023 to 2030 owing to the presence of large target population, and increasing healthcare spending in the region.
Grand View Research has segmented the global flow diverters market based on diameter size, and regions:
Flow Diverters Diameter Size (Revenue, USD Million, 2018 - 2030)
2-3 mm Flow Diverters
3-4 mm Flow Diverters
4-5 mm Flow Diverters
>5 mm Flow Diverters
Flow Diverters Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Norway
Denmark
Sweden
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Mexico
Brazil
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in Flow Diverters Market
Medtronic plc
Stryker Corporation
MicroVention, Inc. (Terumo Corporation)
Balt
MicroPort Scientific Corporation
Phenox GmbH
Acandis GmbH
Cerus Endovascular Inc.
CERENOVUS (Johnson & Johnson Services, Inc.)
InspireMD, Inc.
"The quality of research they have done for us has been excellent..."